Article
French
ID: <
10670/1.8qilir>
Abstract
This paper analyzes the creation of a research collective around a gene-therapy clinical trial thanks to the concept of boundary-object. It describes the scientific, organizational and regulation dimensions of the trial, and analyzes the different boundary-objects upon which the realization of the trial is based. It then interrogates the way these boundary-objects are challenged by an unexpected event happening during the course of the trial: the pertinence and the robustness of these objects have to be demonstrated again in front of a broader audience. The argument thus points towards the necessity of taking into account the trajectory in time and public space of boundary objects in order to analyze research collectives.